WCLC 2025 - Posters & ePosters-P2.08 .50 Tislelizumab With Chemotherapy as Neoadjuvant Therapy for Unresectable Stage III Lung Cancer: A Single-Arm, Phase II Trial

P2.08 .50 Tislelizumab With Chemotherapy as Neoadjuvant Therapy for Unresectable Stage III Lung Cancer: A Single-Arm, Phase II Trial

Asset Subtitle

Xianming Hou

Meta Tag

Speaker Xianming Hou

Topic Local-Regional Non-small Cell Lung Cancer